59 years old man Hx of stomach adenocarcinoma 20 years ago Hx of chemoradiotherapy cc:gross hematuria.

Slides:



Advertisements
Similar presentations
NPCA data collection on men undergoing radical surgery for prostate cancer Paul Cathcart, NPCA Urology Project Coordinator.
Advertisements

PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Cases in Urological Oncology Dr Manish Patel MB.BS., MMed., FRACS, PhD Urological Cancer Surgeon Westmead Public and Private Hospital Westmead Public and.
DEBATE: What is the Optimal Sequence of Therapies for Stage II-III Adenocarcinoma of the Proximal Stomach? Michael A. Choti, MD Department of Surgery UT.
Great Debates & Updates in GI Malignancies
Haematuria and Urinary Tract Tumours
Breast Cancer in Pregnancy
What is TNM? TNM is a system for classifying malignant tumours ! It is a cancer staging system, which describes the extent of a person's cancer ! Most.
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
High-Grade T1 Bladder Cancer: A Clinical Quandary Daniel Canter, M.D. Assistant Professor of Urology Emory University presentation created for:
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Radical Cystectomy As Early Primary Therapy for T1G3 Bladder Cancer Karim Touijer and Bernard H. Bochner. Memorial Sloan-Kettering Cancer Center.
Management of T1 Kidney Cancer Laparoscopic Surgery
Role of Neck Dissection for Differentiated Thyroid CA Joint Hospital Surgical Grand Round NDH Dr. Alex TSANG.
Meta-analysis of trials of radiotherapy in DCIS Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
THE SIGNIFICANCE OF HISTOLOGICAL SUBSTAGING IN CURATIVE RESECTED T3 COLORECTAL CANCER Karl Mrak & Jörg Tschmelitsch Department of Surgery, Barmherzige.
Surgical Management of Urothelial Carcinoma A 21 st Century Approach Douglas S. Scherr, M.D. Clinical Director, Urologic Oncology Weill Medical College.
In the name of God Isfahan medical school Shahnaz Aram MD.
G.Liguori,G.Pirozzi^, I. Forte, G.Botti, R.Franco, A.La Rocca*, G.Rocco* Istituto Nazionale Tumori Napoli Dip.Anatomia Patologica; Dip.Onc.Sperimentale^;
BLADDER CANCER 1.What proportion of deaths from bladder cancer could be improved if we could do a cystectomy earlier in the right people? 2.Do we allow.
Are there benefits from chemotherapy to early endometrial cancer
Breast Cancer: The Profile Ma. Belen E. Tamayo,M.D. Medical Oncologist Makati Medical Center The Medical City.
Background  Reports of long-term survivors (≥5 years) of locally advanced esophageal cancer (LAEC) have focused mainly on HRQL or GI symptoms  Only.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.
Renal tumours Dr. Hawre Qadir Salih.
Neoplasms of the bladder
Protocols for Advanced Prostate Cancer and/or Local Failure After Radical Prostatectomy Isaac Powell, MD.
Contemporary Treatment Guidelines on Bladder Cancer
Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis? Yair Lotan, Robert S. Svatek, Arthur I. Sagalowsky.
Vulvar Cancer Women’s Hospital,School of Medicine Zhejiang University.
Interesting case. OD yo man with irretrievable rectal TVA on screening colonoscopy, prior transanal excision 8 cm from anal verge Pmhx: hypothyroidism,
 T1 tumors at high risk of progression (high grade, multifocality, CIS, and tumor size, )  In all T1 patients failing intravesical therapy  muscle-invasive.
Pathology.
The Royal Marsden Solitary fibrous tumours The outcomes of 106 patients illustrating the unpredictable biological behaviour N Alexander, K Thway, JM Thomas,
Radical surgery is the preferable treatment option for T1- 2/N0 low rectal cancer Jose G. Guillem, MD, MPH Department of Surgery Memorial Sloan Kettering.
Trends in bladder cancer treatments
What Factors Predict Outcome At Relapse After Previous Esophagectomy And Adjuvant Therapy in High-Risk Esophageal Cancer? Edward Yu 1, Patricia Tai 5,
Bladder Cancer Mark Browning, M.D. ‘ IUSME.
Adjuvant and Neoadjuvant Therapy in Non- Small Cell Lung Cancer Seminars in Oncology 2oo5;32 (suppl 2):S9-S15 Kyung Hee Medical Center Department of Thoracic.
Surgery As Monotherapy for Wilms’ Tumor Lisly Chéry April 15, 2010.
IMMEDIATE VS DELAYED NEPHRECTOMY IN WILMS TUMOR Kevin Sullivan, MD UW General Surgery, R1 June 11, 2015.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
Supraclavicular metastasis from urothelial bladder carcinoma: A case report S. Farmahan, T. Mirza, P. Ameerally Oral Maxillofacial Department, Northampton.
Urothelial tumors Tumors in the collecting system above the bladder are relatively uncommon. These tumors are classified into : 1 benign papilloma. 2-papillary.
CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.
Fig. 1: Regional abdominal lymph node dissection during 2-field LND. Fig. 2: full mobilisation of spleen and pancreatic tail to allow complete LND of.
Gallbladder Cancer Surgical Management
Bladder Cancer R. Zenhäusern.
Karcinom rektuma- management
Lymph Node Dissection for Renal Cell Carcinoma: When, How and Why?
Surgical Treatment in Locally Advanced Prostate Cancer
Bladder Cancer and Prostatic Cancer
1 LINFOADENECTOMIA Alessandro Volpe Università del Piemonte Orientale
Endoscopic Treatment of Upper Tract Urothelial Tumours
New perioperative risk factors for biochemical recurrence after robotic assisted radical prostatectomy: A single surgeon experience in high volume Canadian.
Prognosis of younger patients in non-small cell lung cancer
Prof.S.M.Haider Faisal Hameed Wahab Kadri
Volume 61, Issue 1, Pages (January 2012)
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Volume 71, Issue 6, Pages e171-e172 (June 2017)
Vulvar Cancer Women’s Hospital,School of Medicine Zhejiang University.
Volume 61, Issue 5, Pages (May 2012)
SORVEGLIANZA ATTIVA DELLE PICCOLE MASSE RENALI
Volume 67, Issue 6, Pages (June 2015)
흉부영상집답회 case review 강동경희대병원 이한나.
Urinary bladder cancer
Presentation transcript:

59 years old man Hx of stomach adenocarcinoma 20 years ago Hx of chemoradiotherapy cc:gross hematuria

 Cytology:doubtful malignancy  PSA:  Cr: 1.1  USG: Bladder mass  TURBT&PROSTATE Bx was done

Bladder:High grade TCC+CIS prostate:GS 3+4

GI biopsy :NL

RADICAL CYSTOPROSTATECTOMY WAS DONE Ureteral frozen sections:negative

EAU  In all T1 tumours at high risk of progression (i.e. high grade, multifocality, carcinoma in situ, and tumour size, as outlined in the EAU EAU: European Association of Urologyguidelines for Non-muscle- invasive bladder cancer [32]), immediate radical cystectomy is an option.  In all T1 patients failing intravesical therapy, cystectomy should be performed.

Urothelial CIS with prostatic duct involvement prostate:GS 3+3 left ureter:CIS

 18 MONTHS AFTER RADICAL CYSTECTOMY URIN CYTOLOGY IS POITIVE

CYTOLOGY:NEG

 In the case of CIS, an attempt is made to achieve a negative margin without compromising ureteral length because nephrectomy is not indicated for CIS of the uretCIS of the ureter is not independently associated with a worse outcome following cystectomy (Lee et al, 2006). Cancer recurrence at the anastomosis is rare even with a positive margin showing CIS, but a positive margin is a risk factor for developing a second primary tumor of the ureter or renal pelvis (Lee et al, 2006; Raj et al, 2006).

 Surveillance ureteroscopy is the most sensitive means for following patients with a positive ureteral margin, and long-term follow-up is required. The median time to occurrence in one recent series was 53 months (Wagner et al, 2008).

BJU Int.BJU Int Mar;109(6): doi: /j X x. Epub 2011 Aug 4. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. Bladder cancer recurrence forebodes poor prognosis, with 6 months' median survival following recurrence. Advanced pathological stage, positive surgical margins, high lymph node density and early recurrence portends poorer outcome. Although patients with local recurrence have a slightly better prognosis, those with disease recurrence at local and distant sites perform very poorly; nearly 97% of all patients with recurrence eventually succumb to the disease. Chemotherapy administration following recurrence may improve survival, although further studies are needed to exclude selection bias.

J Urol.J Urol Jun;183(6): doi: /j.juro Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. Positive soft tissue surgical margin is a strong predictor of recurrence and eventual death from urothelial carcinoma of the bladder. Soft tissue surgical margin status should always be reported in the pathological reports after radical cystectomy. Due to uniformly poor outcomes patients with positive soft tissue surgical margins should be considered for studies on adjuvant local and/or systemic therapy.

Eur Urol.Eur Urol Apr;63(4): doi: /j.eururo Epub 2012 Sep 28. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma. CONCLUSIONS: We present the first explorative study on the prognostic impact of pnLVI. In contrast to other parameters that show the extent of LN metastasis, pnLVI is an independent prognosticator for CSS.

Prog Urol.Prog Urol Oct;22(12): doi: /j.purol Epub 2012 Aug 29. [Radical cystectomy for urothelial bladder cancer: prognostic impact of lymph node metastasis and soft tissue surgical margins]. Positive soft tissue surgical margin and/or lymph node metatstasis on cystectomy specimen is a strong predictor of GS and SS from urothelial carcinoma of the bladder. So it is for capsular rupture, ganglionic density greater or equal to 0.10 and nb of N in lymphadenectomy less than 14 for pN+ patients.

J Urol.J Urol Dec;178(6): ; discussion Epub 2007 Oct 22. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. Risk factors for positive soft tissue surgical margins are female gender, locally advanced cancer, presence of vascular invasion and mixed histology. Patients with positive soft tissue surgical margins have poor prognosis, and positive soft tissue surgical margins were found to be independently associated with disease specific death.

World J Urol.World J Urol Aug;29(4): doi: /s z. Epub 2010 Jul 9. Sequential resection of malignant ureteral margins at radical cystectomy: a critical assessment of the value of frozen section analysis. FSA has a high accuracy for detecting malignant ureteral margins. Patients with positive final margins are at increased risk of UUT-R. With sequential resection, however, positive margins cannot reliably be converted to negative ones.

Int Urol Nephrol.Int Urol Nephrol Dec;44(6): doi: /s y. Epub 2012 Jul 7. The incidence and relevance of prostate cancer in radical cystoprostatectomy specimens. The majority of incidental CaP in CP specimens are organ confined and do not influence oncological outcome. The prognosis of such patients is primarily determined by bladder cancer. Our findings support previous reports and autopsy studies elsewhere.